With Affini-T Therapeutics, the Fred Hutchinson Cancer Research Center investigator may finally have his chance. The company announced $175 million… Read More New funding: Affini-T Therapeutics ...

Days after the feds canceled contracts for an historic women-focused health initiative, the agency appears to be restoring ...

Facing federal funding uncertainty, a looming workforce shortage and an increasingly aging patient population, cancer center leaders in the U.S. remain undeterred. Their focus remains, as it has for ...

Research institutions at 27 sites in the U.S. and Canada ... in immunotherapy funded by the National Cancer Institute and headquartered at Fred Hutchinson Cancer Research Center. CITN will establish a ...

a member of the Clinical Research and Public Health Sciences divisions at Fred Hutchinson Cancer Research Center, will present recent groundbreaking developments in treating pancreas cancer with ...

Women who survive cancer are more likely to experience cancer-related fatigue and depression than men, according to new ...

Julie McElrath, M.D., Ph.D., is director of the HVTN Laboratory Center and is senior vice president and director of the Vaccine and Infectious Disease Division at Fred Hutchinson Cancer Research ...

Allegations of patient deaths and conflicts of interest in a 13-year-long clinical trial at the Fred Hutchinson Cancer Research Center in Seattle, has prompted a class action lawsuit by 82 ...

The findings from Fred Hutch Cancer Center suggest next step of exploring whether one dose of the vaccine is enough.

Based on pioneering research at Fred Hutch, this powerful treatment continues to save lives worldwide. Thanks to our generous supporters, Fred Hutch is redefining cancer and infectious disease for the ...

No identified affiliates for Fred Hutchinson Cancer Center in the 2024 election cycle. Contributions to 527s are not included in the Individuals, PACs, Soft (Indivs), or Soft (Orgs) columns, so the ...